Alignment Healthcare, INC Form 4 insider transactions

John E Kao, Chief Executive Officer and a Director of Alignment Healthcare, Inc., sold 298,000 shares of common stock on August 10, 2026 for $13.88 per share.

Dawn Christine Maroney, President of Alignment Healthcare, Inc., sold 177,068 shares of common stock on July 15, 2026 for $20.83 per share.

John E Kao, Chief Executive Officer and a Director of Alignment Healthcare, Inc., sold 298,000 shares of common stock on July 10, 2026.

Alignment Healthcare, Inc. reports a transaction where EVP Joseph S. Konowiecki sold 25,000 shares of common stock.

Joseph S. Konowiecki, EVP Corporate Affairs and Director at Alignment Healthcare, Inc., reported a sale of 25,000 common shares.

Joseph S. Konowiecki, EVP of Corporate Affairs at Alignment Healthcare, Inc., reported a sale of 25,000 common shares.

Alignment Healthcare President Dawn Maroney sold 30,000 shares of common stock via a pre-arranged 10b5-1 trading plan.

Chief Medical Officer Hyong Kim sold 35,951 shares of Alignment Healthcare, Inc. common stock.

CEO John Kao executed a planned sale of 298,000 shares of Alignment Healthcare common stock under a Rule 10b5-1 trading plan.

Mark D. Kent, President - MSO of Alignment Healthcare, Inc., acquired 87,719 restricted stock units on June 3, 2026.

Joseph S. Konowiecki, EVP Corporate Affairs and Director at Alignment Healthcare, Inc., acquired 122,807 restricted stock units on June 3, 2026.

Mark D. Kent, President of MSO at Alignment Healthcare, Inc., acquired 14,848 shares of common stock at $13.31 per share.

Dawn Christine Maroney, President of Alignment Healthcare, Inc., reported transactions involving the sale and gifting of common stock.

Alignment Healthcare CEO John E. Kao reported the sale of company stock valued at over $4.7 million through multiple transactions executed on May 11, 2026.

Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare CEO John E. Kao has reported the sale of company stock totaling over 300,000 shares across multiple transactions in April 2026, executed under a Rule 10b5-1 trading plan.

Alignment Healthcare's Chief Financial Officer, James M. Head, reported a sale of 11,100 common shares to cover tax withholding obligations upon the vesting of restricted stock units.

Alignment Healthcare, Inc. CEO John E. Kao reported the sale of company stock valued at over $40 million through a Rule 10b5-1 trading plan.

Alignment Healthcare's Chief Legal and Admin. Officer, Christopher J. Joyce, sold 18,013 shares of common stock for approximately $17.79 per share.

Alignment Healthcare CEO John E. Kao sold 118,000 shares of common stock for approximately $17.48 per share under a pre-arranged trading plan.

Alignment Healthcare's COO, Sebastian Burzacchi, sold 15,361 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold 18,404 shares of common stock at a weighted-average price of $17.84 to cover tax withholding obligations.

Alignment Healthcare's Chief Legal and Admin. Officer, Christopher J. Joyce, sold 25,125 shares of common stock to cover tax withholding obligations.

Alignment Healthcare President Dawn Maroney sold 36,749 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Alignment Healthcare CEO John E. Kao sold 73,046 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Alignment Healthcare's Chief Information Officer, Robert L. Scavo, sold 11,285 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Alignment Healthcare's Chief Human Resources Officer, Andreas P. Wagner, sold shares to cover tax obligations and under a pre-arranged 10b5-1 plan.

Alignment Healthcare, Inc. granted 23,543 restricted stock units to Chief Human Resources Officer Andreas P. Wagner, vesting over three years.

Alignment Healthcare's COO, Sebastian Burzacchi, was granted 36,198 restricted stock units, vesting over three years.

Alignment Healthcare's Chief Digital Officer, Adnan R. Mansour, was granted 25,015 restricted stock units, vesting over three years.